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Abstract
Background: While many biological studies can be performed on cell-based systems, the investigation of molecular
pathways related to complex human dysfunctions – e.g. neurodegenerative diseases – often requires long-term studies
in animal models. The nematode Caenorhabditis elegans represents one of the best model organisms for many of
these tests and, therefore, versatile and automated systems for accurate time-resolved analyses on C. elegans are
becoming highly desirable tools in the field.
Results: We describe a new multi-functional platform for C. elegans analytical research, enabling automated worm
isolation and culture, reversible worm immobilization and long-term high-resolution imaging, and this under active
control of the main culture parameters, including temperature. We employ our platform for in vivo observation of
biomolecules and automated analysis of protein aggregation in a C. elegans model for amyotrophic lateral sclerosis
(ALS). Our device allows monitoring the growth rate and development of each worm, at single animal resolution,
within a matrix of microfluidic chambers. We demonstrate the progression of individual protein aggregates, i.e.
mutated human superoxide dismutase 1 - Yellow Fluorescent Protein (SOD1-YFP) fusion proteins in the body wall
muscles, for each worm and over several days. Moreover, by combining reversible worm immobilization and on-chip
high-resolution imaging, our method allows precisely localizing the expression of biomolecules within the worms’
tissues, as well as monitoring the evolution of single aggregates over consecutive days at the sub-cellular level. We also
show the suitability of our system for protein aggregation monitoring in a C. elegans Huntington disease (HD) model,
and demonstrate the system’s ability to study long-term doxycycline treatment-linked modification of protein
aggregation profiles in the ALS model.
Conclusion: Our microfluidic-based method allows analyzing in vivo the long-term dynamics of protein aggregation
phenomena in C. elegans at unprecedented resolution. Pharmacological screenings on neurodegenerative disease
C. elegans models may strongly benefit from this method in the near future, because of its full automation and
high-throughput potential.
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Background
The growing incidence of neurodegenerative diseases
(NDs) urges for a complete understanding of the molecu-
lar processes underlying neurodegeneration, as a first step
towards the final promise of a new class of therapeutics
for these diseases. Cellular models have been exploited for
some of these studies [1, 2], but the high complexity of
the molecular mechanisms implicated in NDs increasingly
demands in vivo models for the investigation of complex
phenotypes, which are determined by the interplay among
different tissues and pathways [3]. The nematode Caenor-
habditis elegans represents a very convenient model
organism for such in vivo tests, mainly because of its very
fast life cycle, combined with the ease of its genetic
manipulation and the relatively high level of conserved
mechanisms between C. elegans and humans [4]. In the
last two decades, several protein-misfolding disorders,
including age-related NDs, have been successfully mod-
eled in C. elegans indeed [5]; libraries of transgenic worms
are currently available for the research of the molecular
mechanisms underlying Alzheimer’s, Parkinson’s and
Huntington’s diseases, as well as ALS [3]. Transgenic
expression of disease genes in C. elegans is typically visual-
ized via fluorescently tagged proteins within its transparent
tissues. In most of the NDs, specific proteins self-assemble
into aggregated species and cellular toxicity can be induced
by the protein misfolding and aggregation process itself [3].
Therefore, the spatio-temporal-resolved observation of
protein expression and aggregation, associated with the
quantification and localization of these aggregates is a key
analytical method for the in vivo monitoring of disease
evolution. Unfortunately, conventional C. elegans handling
and imaging techniques do not allow accurate monitoring
of aggregate progression in individual worms over time,
since nematodes are typically cultured in large populations
on agar plates and irreversibly immobilized by means of
anesthetics for high-resolution imaging.
The advent of microfluidics within the C. elegans
research community is progressively revolutionizing the
field [6–9]. In particular, several miniaturized devices
proved their potential in neurobiology studies, such as
the investigation of C. elegans oxygen sensation [10],
olfactory [11] and chemosensory [12] neuronal activity, ex-
ploratory and learning behavior [13], neurotoxin-induced
responses [14], neuromuscular function [15], and nerve
regeneration [16, 17]. In the neurodegeneration research
field, Càceres et al. [18] recently proposed a microscale
system for high-throughput visual screens on worms. This
system exploited a curved microchannel geometry to trig-
ger the positioning of nematodes into lateral orientations
and facilitate the inspection of D-type motor neurons.
Although this device allowed efficiently screening mutants
carrying neurodegenerative defects, it did not permit
longitudinal monitoring of the worms. Other microfluidic
platforms have instead demonstrated the feasibility of
continuous worm culture and observation. For example,
Krajniak et al. [19] showed the microfluidic culture of L1-
L3 larvae over periods of 12–36 h, whilst introducing a
method for worms’ reversible immobilization based on a
thermo-sensitive sol–gel transition. Other studies demon-
strated the applicability of this immobilization method in
different microfluidic formats [20–22]. However, protein
aggregation monitoring within ND disease models typically
requires worm culture and repeated high-resolution
imaging of the same worm over significantly longer time
periods (e.g. > 3 days). This imposes severe requirements in
terms of system robustness and automation, related to the
simultaneous and strict control of environmental condi-
tions, like worm feeding, fluidic exchanges, temperature of
the microfluidic environment, etc.. In this perspective,
Rohde et al. [23] demonstrated an elegant automated sys-
tem for in vivo time-lapse imaging and high-throughput
screening of C. elegans in standard multiwell plates, which
employed an in-well cooling apparatus for reversible worm
immobilization. However, the use of this device for protein
aggregation monitoring at single animal resolution is less
trivial, as it did not have microfluidics on-board and could
not exploit brightfield transmission microscopy as analytical
tool. Here we introduce a microfluidic-based methodology
for long-term and high-resolution monitoring of protein
aggregation and automated analysis of C. elegans ND
models. Specifically, we demonstrate the feasibility of in
vivo observation, over 4 days at single animal resolution, of
SOD1 aggregation in the AM725 C. elegans transgenic
strain, which we use as a biological model system for the
investigation of the human ALS disease. This is enabled by
our microfluidic platform, which co-integrates the following
options and functionalities: (i) a method for fast confine-
ment of worms of desired age in microfluidic chambers, by
means of pure passive hydrodynamics with no need of any
active components, such as integrated valves; (ii) a tech-
nique for continuous worm feeding and progeny removal,
to preserve the on-chip worm identity over long-term stud-
ies; (iii) a method for reversible C. elegans immobilization
using a hydrogel, enabling high-resolution imaging at
arbitrarily selected moments of their whole lifespan; (iv) an
integrated active temperature control system, both to set
precise environmental conditions for C. elegans mainten-
ance and to automatically steer the worm immobilization/
release process; (v) a compact device assembly, readily
adaptable to host different microfluidic designs and suitable




Our worm culture and imaging platform features different
components (Fig. 1a). Worms are manipulated inside a
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monolithic polydimethylsiloxane (PDMS) microfluidic
chip, conceived as a simple 1-layer device and operating
via pure passive hydrodynamics, with no need of any
active valving system. The chip is bonded to a standard
150 μm-thick glass coverslip for accurate worm imaging
through high-magnification oil immersion objectives. An
aluminum frame is specifically designed to host the chip
and set a well-defined temperature distribution over its
whole three-dimensional (3D) geometry. Both the frame
and the top of the PDMS chip are positioned in contact
with a thermoelectric module used to set the temperature
of the assembly. A central hole in the Peltier module
allows light transmission through the PDMS chip, there-
fore enabling worm imaging via transmission microscopy.
A well-dimensioned heat sink ensures the dissipation of
excess heat produced by the thermoelectric module; a
thermally insulating holder allows positioning the device
on the microscope stage while preventing thermal dissipa-
tion. The entire structure is held together by screws and
springs at the four corners, in order to ensure good
thermal contacts throughout the stack. A resistive
temperature detector (RTD), in contact with the glass sub-
strate, is employed to sense the temperature of the micro-
fluidic device. The signal measured by the sensor is
exploited to set the power provided to the thermoelectric
module in a closed-loop configuration, for active control
and constant monitoring of the temperature experienced
by the worms inside the chip. The feedback loop manage-
ment is committed to a portable PID controller (Fig. 1b),
provided with a software interface. The microfluidic flow
inside the device is regulated by computer-controlled
syringe pumps. The tubing connecting the chip to the
external syringes are directly plugged to the sidewalls of
the PDMS device. To get this peculiar configuration, we
casted PDMS inside a specifically designed mold, allowing
to shape its whole 3D structure (Additional file 1:
Supplementary Note 1). Lateral tubing connections are
employed to partially embed the tubes in the aluminum
thermalization frame, therefore putting them in contact
with the Peltier module as well (Fig. 1c). This allows pre-
thermalizing the liquids prior to their injection inside the
PDMS chip and opens the possibility of tuning the chip
temperature through the injected liquid as well, as will be
clarified further. Moreover, the lateral positioning of the
microfluidic tubing makes our device readily suitable for
imaging on both upright and inverted microscopes. Size
and shape of the device holder allow perfect fit with any
microscope stage or equipment compatible with standard
60 mm Petri dishes. The imaging area available for
transmission microscopy has about 15 mm in diameter,
corresponding to the central hole of the thermoelectric
module (Fig. 1c). This represents the only geometrical
constrain in the design of the PDMS chip, thus offering
full versatility in using multiple microfluidic layouts. In
particular, for our studies, we use three different microflui-
dic architectures, featuring matrices of worm culture
chambers of different shapes and sizes (Fig. 1d).
Worm arraying via passive valves
Passive hydrodynamics allows avoiding the need of
additional fluidic control layers or active valving systems,
which would complicate use and design of the chip and
would reduce its ease of automation. The first critical
protocol steps are typically represented by synchronization,
loading and distribution of the worms inside the device. In
our platform, all these operations are simultaneously
accomplished by simply injecting a mixed worm suspen-
sion into the microfluidic chip at a proper flow rate, along
the In1-Out1 direction (Fig. 2a). We mainly worked with
three different chip designs (Fig. 1d) for selecting either L1,
L2/L3 or L4 larvae, as these are commonly employed
stages for worm synchronization and successive analyses.
Fig. 1 a Schematic representation of the main constitutive components of the microfluidic platform. b Photograph of the device, with schematic
picture of the closed-loop temperature control system. c Section view of the device assembly, with a zoom on a microfluidic design within the
imaging area. Scale bar = 2 mm. d Representative microfluidic geometries for use with the platform, featuring matrices of (i) 1, (ii) 4 and (iii) 32
worm culture chambers. Scale bars = 200 μm
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Size and shape of the microfluidic channels connecting ad-
jacent chambers along the In1-Out1 direction are designed
to ensure uniform flow distribution across the chambers
and allow access to the chip only to worms which are
younger than the desired age – and thus smaller than a
certain size. More specifically, we exploit the flexible na-
ture of PDMS to trigger a passive valving mechanism [24]
in the channels (zoom of Fig. 2a). In the “L1 design”
(Fig. 1diii), only L1 worms can access the culture cham-
bers because of their smaller size, which is compatible
with the passage through microfluidic channels sizing 8 ×
14 μm2 in section. When a 1 s pulse of 2 μL inflow is
injected into the device, a slight overpressure instantan-
eously builds up inside the channels, causing a fast tem-
porary increase of their section. This triggers the passage
of L1 larvae through the channels (Fig. 2b and Additional
file 2: Video S1). The end of the pulse results then in
worm confinement inside the chambers, since each chan-
nel immediately returns to its initial shape, preventing any
spontaneous passage of worms. A few subsequent inflow
pulses allow distributing L1 larvae over the whole matrix
of 32 chambers in a few seconds. The same principle is
employed in the L4 and L2 chip designs (Fig. 1di-dii), for
the automated dispensing of larvae in a single culture
chamber or in the 4 chamber array. In this case micro-
channels (60 × 14 μm2 and 30 × 14 μm2 in section for the
L4 and L2 designs, respectively) are sized as such to block
the passage of adult worms, confine larvae of desired size
inside the chambers by the passive valving effect, while
directly washing all the smaller larvae out of the chip.
Eventually, direct user control and iteration of the
worm loading protocol can be used to adjust the
worm distribution until a desired number of worms
per chamber is obtained.
Temperature control system design and characterization
We investigate the performance of our temperature control
system both theoretically (Additional file 1: Supplementary
Note 2) and experimentally. The setup can be operated
either in “closed-loop configuration” – by means of the PID
controller – or in “open-loop mode”, i.e. by providing the
Peltier module with a constant electrical power. The former
configuration results in fully automated control of the setup
temperature, the latter option has the advantage of allowing
device operation with no need of a feedback sensing
system. To extract the “open loop” calibration curve of our
device, we first characterize its response for different
constant cooling electrical powers (Fig. 3a). In this study,
the temperature is measured by means of a 1.6 × 2.5 mm2
Pt1000 sensor positioned on the bottom face of the glass
coverslip, aligned with the center of the microfluidic chip
(at x = y = 0 in the insert of Fig. 3b). Because of the reduced
thickness of the glass substrate, negligible temperature
variations are expected between top and bottom face of the
coverslip. As expected, for different cooling power in the
“open loop” configuration, the system is cooled down to
specific steady-state temperatures, set by the equilibrium
between thermoelectric cooling and heat convection in the
surrounding air. Starting from an ambient temperature of
24 °C, stable temperatures down to 10 °C can be reached at
Fig. 2 a Schematic representation of the worm loading process. A pressure pulse triggers the fast deformation of the PDMS valving channels and
allows the injection of worms of desired size into the culture chamber. b Time-lapse pictures of a valving channel, as obtained from
Additional file 2: Video S1, during the injection of a L1 worm in the chip of Fig. 1diii. Scale bars = 10 μm
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the chip center, with a clear linear dependence on the elec-
trical power that is applied to the Peltier module (Fig. 3b).
Because of the specific geometry of the device, the spatial
temperature distribution is not constant throughout the
chip area, as observed via measurements at different loca-
tions from the coverslip center (Fig. 3c). By fitting these
data with the corresponding simulated results, we empiric-
ally extract the heat transfer coefficient h, which models
heat convection in our system (Equation S2). A slight devi-
ation in the fit between measured and simulated data is ob-
served only close to the PDMS chip edge (y = ± 10 mm)
and attributed to imperfections of the contact surfaces
between the chip and the metallic frame. We moreover
simulate the spatial temperature distribution for different
cooling powers, showing again good agreement between
theoretical and experimental results (Fig. 3c). The dynamics
of heat exchange in our system can be efficiently studied by
normalizing the curves of Fig. 3a with respect to the exter-
nal temperature Text and the steady-state temperature Teq
for each applied power. Normalized data prove to be inde-
pendent from the electrical power and allow defining the
calibration curve that describes the temperature evolution
of the device in the “open loop” configuration (Additional
file 1: Supplementary Note 3). Further enhancement and
fine-tuning of the cooling efficiency of the device are more-
over enabled by controlling the microfluidic inflow speed,
which allows accurately modulating the liquid pre-
thermalization (Additional file 1: Supplementary Note 4).
Automated worm culture and imaging protocol
The cross-shape of our chips, with in- and outflows along
two orthogonal directions, is designed to decouple the
worms’ dispensing operation (in the In1-Out1 direction)
from the worm culture and imaging protocol. Along the
In2-Out2 direction, adjacent chambers are connected by
narrow filters – 5 × 14 μm2 in section – allowing perfusion
of liquids across the whole chamber matrix, while pre-
venting any inter-chamber exchange of worms, even
under over-pressure conditions. Also, after worm dispens-
ing, the In1-Out1 flow direction can be employed during
the culture experiments for evacuating the progeny of the
adult worms under analysis. Each switching between the
two flow directions is simply controlled by two external
valves at the two chip outlets.
We develop a fully automated protocol for worm
culture and high-resolution imaging inside the device
(Fig. 4a). Worms are cultured on-chip at a desired
temperature (typically in the 20–25 °C range) by operating
the temperature controller in a closed-loop configuration.
Escherichia coli suspension is perfused at desired rate
along the In2-Out2 direction for worm feeding (Fig. 4ai).
For screening purposes and high-throughput-like
experiments, our platform can be readily used in
imaging experiments with standard low-magnification
microscope objectives. However, for ultimate imaging
accuracy and repeatable observation of the worms
through high-magnification objectives, C. elegans need
to be temporarily immobilized in a reversible manner.
To fulfil this requirement, we employ the thermoreversi-
ble gelation of a PF127 solution around the worms, as a
minimally invasive C. elegans immobilization technique.
Previously reported results, in fact, proved that both
thermocycling and the exposure to PF127 for repeated
imaging cycles do not alter viability, development and
physiology of C. elegans [19]. Prior to imaging, the chip
temperature is set at 15 °C and a liquid solution of
25 % w/v PF127 is injected into the culture chambers
(Fig. 4aii). The chip temperature is then raised to 25 °C, to
trigger the gelation of the Pluronic solution. This signifi-
cantly increases the viscosity ensuring stable worm
immobilization (Fig. 4aiii and Additional file 3: Video S2).
Upon imaging, the chip temperature is brought back to
15 °C, to release the worms and wash the PF127 solution
out of the chambers, by replacing it with E. coli suspen-
sion to restart worm culture and feeding (Fig. 4aiv). The
whole protocol can be iterated many times per experiment
Fig. 3 a Experimental characterization of the device cooling performance in “open-loop” configuration, for different cooling power applied to the
thermoelectric module starting from t = 0 and an external temperature of 24 °C (temperature sensor positioned at the chip center). b Measured
equilibrium temperature Teq at the chip center (x = y = 0) for different constant cooling power and starting from an external temperature Text = 24 °C.
N = 3, errors are SD. c Spatial temperature distribution across the chip area, both measured experimentally and simulated via FEM
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and strongly relies on accurate temperature control, espe-
cially to trigger the worm immobilization/release process.
The closed-loop temperature management system plays
therefore a crucial role for the device automation. The
spatial distribution of temperature over the whole chip
geometry is carefully considered, to minimize inter-
chamber variations and expose all the worms to the same
experimental conditions. We demonstrate via FEM simu-
lations that our device ensures temperature uniformity
within 1 °C difference, even when using the largest cham-
ber matrix, and this both during worm culture (at 20 °C)
and PF127 injection and washing (at 15 °C) (Fig. 4b). PID
parameters are chosen to minimize any overshoots out-
side of the standard temperature range for worm culture
(15–25 °C) (Fig. 5a). Active temperature control allows
moreover fast and accurate steering of the sol–gel transi-
tion of the PF127 solution. In our device, such a transition
occurs about 1 min after the temperature setpoint shift
from 15 °C to 25 °C , i.e. worms are ready for high-
resolution imaging in about 2–3 min, when the viscosity
of the PF127 gel reaches its highest value and guarantees
worm immobilization (Fig. 5b). We experimentally deter-
mine the viscosity at different temperatures by dispensing
a ~2 mL PF127 solution over the bottom plate of a cone-
plate viscometer (Bohlin Gemini Malvern, UK) and meas-
uring using a shear rate of 10 s−1. This value is chosen to
be comparable with typical shear rates associated to the C.
elegans swimming motion (1–20 s−1) [25]. Finally, we
attribute a crucial role to the liquid inflow pre-
thermalization as far as the PF127 injection process is
concerned. Even in liquid phase, the PF127 solution
behaves in fact as a very viscous non-newtonian fluid, and,
as such, it is challenging to manipulate through syringes,
tubes and microchannels. Pre-thermalizing the PF127
inflow in the metallic frame to temperatures even lower
than 15 °C allows further reducing the solution viscosity
at the chip inlet and improving the control over its
injection.
Long-term protein aggregation analysis in an
amyotrophic lateral sclerosis (ALS) C. elegans model
Upon full validation of worm viability and culture in our
device (Additional file 1: Supplementary Note 5), we em-
ploy it to monitor the dynamics of protein aggregation
Fig. 5 a Experimental temperature at the chip center during a worm
culture-to-imaging transition, as managed by the active temperature
control system, indicating the periods of PF127 injection and chip
temperature changes. b Temperature rise in the 15–19 min period in
more detail. The axis on the right shows the variation of PF127 solution
viscosity (25 % w/v in water) during the transition from 15 to 25 °C in
the device. The PF127 sol–gel transition occurs abruptly at about 17 °C,
in a time window of ~1 min. Values of PF127 viscosity at the different
temperatures are measured through a cone-plate viscometer
Fig. 4 a Schematic representation of the iterative worm culture and
imaging protocol. b FEM simulations of the spatial temperature
distribution over the chip area (temperature contour plots) for
temperature setpoints (i) at 20 °C for culture and (ii) at 15 °C for imaging
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in an ALS disease C. elegans model. ALS is a neurodegen-
erative human disease causing selective death of motor
neurons. In Europe and the United States, this disease
affects about 2 people per 100,000 per year [26], with aver-
age survival from onset to death of only 3–5 years and no
cure currently available [27]. In ALS, such as in many
other neurodegenerative diseases, cellular toxicity could
be mediated by the misfolding and aggregation of specific
mutant proteins [28–30]. Time-resolved imaging and
quantification of these aggregates is hence a key pheno-
typing method to monitor disease progression. In our
study, we employ an ALS C. elegans model expressing
mutated human SOD1-YFP fusion proteins in the body
wall muscle cells (AM725 transgenic worms) [31] While
this model presents some limitations for investigating
neurodegeneration per se, compelling evidence in litera-
ture already proved that C. elegans models expressing pro-
tein aggregation in muscle cells are useful for screening
neurodegenerative phenotypes about Parkinson’s and
Huntington’s diseases [32–34]. In our device, worms are
loaded at the L2 stage into a 4-chamber microfluidic chip
(Fig. 1dii), where their distribution is adjusted to isolate a
single worm in each chamber. Automated on-chip culture
of these worms is then conducted according to the previ-
ously described protocols. Correct worm feeding, develop-
ment and reproduction are constantly monitored via
brightfield time-lapse imaging (Fig. 6a). Automated image
processing algorithms on these time-lapse pictures allow
moreover extracting detailed information about the
worms’ growth rate, not only at a population level, but also
at single-worm resolution (Fig. 6b-c). Specifically, the area
occupied by each worm is here used as a quantitative indi-
cator of growth. Data about the growth rate of individual
worms allows preserving detailed information on the de-
velopment of each nematode (Fig. 6b), while the average
growth trend is found to follow a well-defined sigmoidal
dependence on time (Fig. 6c). At desired moments during
worms’ development (e.g., in our study, 43 h, 60 h and
91 h upon worm injection), the reversible worm
immobilization protocol for high-resolution imaging (see
Fig. 4a) is employed. At each observation and in a matter
of a few minutes, all the worms are perfectly immobilized
in a PF127 gel matrix and SOD1-YFP expression can be
monitored within their tissues via fluorescent microscopy
through high-magnification objectives. A first analysis at
10× magnification allows observing protein aggregates
within the whole body of each worm (Fig. 7a). Aggrega-
tion patterns observed in our system are in line with pre-
viously reported results: while wild-type SOD1 is known
to exhibit only diffuse fluorescence in body wall
muscle cells, mutant SOD1 proteins present punctu-
ated fluorescent patterns [31]. Interestingly, we find
that the temporal evolution of SOD1-YFP aggregation
features some observable worm-to-worm variability
(Fig. 7b), and follows an increasing trend in the considered
temporal window (43–91 h after on-chip loading at the L2
stage) (Fig. 7c).
A second set of studies is then conducted by imaging
the immobilized worms through a 63× oil immersion
objective (NA 1.4). Many aggregates in AM725 worms,
unlike in other analogous SOD1-transgenic strains – e.g.
pUnc-54::SOD1-G85R::YFP (G85R) and pUnc-54::SOD1-
G93A::YFP (G93A) –, appear as irregular, elongated foci
[31]. This feature could be observed before by confocal
imaging of paralyzed worms. We are now able to con-
firm this observation in alive immobilized worms and
provide a precise sub-cellular mapping of their protein
aggregation pattern at high spatio-temporal resolution
by using a standard fluorescent microscope (Fig. 7d).
Moreover, the possibility to take quasi-instantaneous
brightfield and fluorescent pictures in our chip allows
accurately locating each fluorescent signal inside the C.
elegans body. In combination with reversible worm
immobilization, this opens the possibility of following
the temporal evolution of protein aggregation at precise
locations within the worm tissues and monitoring
Fig. 6 a Time-lapse brightfield pictures of four AM725 transgenic worms, isolated at t = 0 at the L2 larval stage in the 4 different culture chambers.
Scale bars = 100 μm. b On-chip growth rate of the four worms over 87 h, as estimated by measuring the worm area from time-lapse pictures.
c) Average on-chip worm growth, featuring a sigmoidal time-dependence
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aggregate progression in vivo, not only at single-worm,
but even at the single-cell level (Fig. 7e).
Long-term protein aggregation analysis in a Huntington
disease (HD) C. elegans model
To ascertain that this approach is not specific only for
the ALS model, we monitor the dynamics of protein ag-
gregation in a different C. elegans model of neurodegen-
erative diseases, i.e. a Huntington disease (HD) model
(Additional file 1: Supplementary Note 6). More particu-
larly, we employ a HD model expressing YFP fused to
stretches of 35 glutamine residues (AM140 transgenic
strain) [35]. Our system allows the observation of
distinct aggregation patterns for this model and allows
following the long-term evolution of both aggregate size
and number, with results in line with what has been pre-
viously reported [35]. Furthermore, the specificity of the
approach to monitor the aggregates is validated by using a
strain expressing the YFP only in the body wall muscles
(AM134 strain) and showing only a diffuse fluorescence in
these tissues [35].
Modifying long-term protein aggregation in an ALS C.
elegans model by doxycycline treatment
ALS is the most common motor neuron disease in
adults, causing the selective loss of the spinal and cranial
motor neurons cells that directly connect the brain to
muscles. The disease is characterized by rapidly progres-
sive paralysis and death from respiratory failure, typically
within 2–3 years of symptom onset [36]. There are
currently no effective cures for ALS, although Riluzole
was found to slow the rate of progression and prolongs
survival by 3 months [36]. Mitochondrial accumulation of
misfolded mutant SOD1 has been proposed as one pos-
sible trigger of motor neuron death [37]. Mitochondrial
degeneration [38], vacuolization and swelling [39] are
pathological features of both familial human ALS cases
and mutant SOD1 mouse models. Hence, damaged or
dysfunctional mitochondria are common in most familial
ALS cases and could represent a potential therapeutic
target for treatment of this disease. Activation of the
mitochondrial unfolded protein response (UPRmt) recently
emerged as an interesting approach to restore a pool of
healthy, functional mitochondria in stressed animals and
maintain organism health [40]. Indeed, genetic or pharma-
cological inductions of UPRmt can extend the lifespan in
various model organisms, including worms [41–43]. Bene-
ficial effects of UPRmt rely on the massive expression of
mitochondrial chaperones that help to repair the damages
caused in the organelle [44]. Doxycycline –an antibiotic
belonging to the tetracycline family– proved to be benefi-
cial for certain physiological aspects, like for increasing
the motility in worms and flies, and extending the lifespan
of worms through the activation of UPRmt [42, 45]. To
determine whether UPRmt could prevent the ALS progres-
sion in C. elegans, we treat worms with doxycycline and
monitor the aggregate formation. First, in order to evalu-
ate the efficacy of doxycycline treatment in our microflui-
dic system, we need to monitor the induction of the
UPRmt. We therefore use a transgenic strain of worms that
reports on the activity of the UPRmt with integrated GFP
genes driven by the regulatory DNA region of the mito-
chondrial chaperone hsp-6 [46]. In these transgenic
worms, an increase of hsp-6::gfp expression is indicative of
Fig. 7 a Time-lapse fluorescent pictures of four AM725 transgenic worms, immobilized in a PF127 gel matrix within the culture chambers. Scale
bars = 100 μm. b Growth rate of SOD1-YFP aggregates in the body wall muscle cells of each worm, as estimated by measuring YFP expression
area across each worm’s body during their immobilization in the gel matrix. c Average protein aggregate/worm area over time. For each worm
and each time-point, the aggregate area is normalized by the worm area to take into account the size variability of each worm. A clear time-
dependent increase of these values is observed over the period from 43 to 91 h upon loading on chip (day 1 to day 3 of worm adulthood).
d Brightfield and fluorescent images of an immobilized worm (worm 1), as taken through a 63× NA 1.4 oil immersion objective 91 h upon worm
loading into the device. These pictures allow mapping the aggregate morphology at high spatio-temporal resolution. e Superimposed brightfield
and fluorescent images of an immobilized worm (worm 4), as taken through a 63× NA 1.4 oil immersion objective 43 and 60 h upon worm
loading into the device. Arrows point at specific SOD1-YFP aggregates, which can be re-identified in subsequent images and tracked over time.
Scale bars = 20 μm
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the presence of a mitochondrial stress and the subsequent
induction of the UPRmt [46]. As previously observed on
solid nematode growth media (NGM) plates [42], doxy-
cycline dose-dependently also induces the expression of
the hsp-6::gfp on-chip, revealing the activation of the
UPRmt (Fig. 8a). At the same time, doxycycline also in-
duces a significant growth delay, which is another known
physiological effect produced by the antibiotic (Fig. 8b)
[45]. Based on these first observations obtained from the
hsp-6::gfp expressing worms, we decide to use a concen-
tration of 15 μg/mL doxycycline in our microfluidic exper-
iments on the ALS worm model, as (1) this concentration
is comparable to the concentrations showing a significant
effect on the worm lifespan and on the UPRmt on solid
plates, and (2) the impact on the growth of this concentra-
tion is minor. Moreover, we treat ALS worms with doxy-
cycline and compare the aggregation pattern with that of
an untreated population. Strikingly, doxycycline treatment
suppresses almost completely the size expansion of the
aggregates, without affecting their number (Fig. 8c-d).
Protein aggregation diseases are often associated with
movement disorders, and worm models of neurodegener-
ative diseases also recapitulate this feature [31, 35, 47–49].
Interestingly, doxycycline treatment significantly slows
down the progressive loss of motility in the ALS strain, as
observed on NGM plates (Fig. 8e). Since doxycycline is
Fig. 8 a-b Analysis of the efficacy of doxycycline treatment in our microfluidic system. (ai) Quantification of hsp-6::gfp expression in young adult
SJ4100 worms, treated on-chip with doxycycline at concentrations of 0, 15 and 30 μg/mL, starting from the L1 stage. (aii) Representative fluorescent
pictures of young adult worms upon image thresholding, as used for the quantification of hsp-6::gfp expression. Scale bars = 200 μm. (bi) Quantification
of the development time to the young adult stage in SJ4100 worms, treated on-chip with doxycycline at concentrations of 0, 15 and 30 μg/mL,
starting from the L1 stage. (bii) Representative brightfield pictures of young adult worms, as used for the monitoring of the development time. Scale
bars = 200 μm. c-d Temporal evolution of (c) the average size and (d) the average number of aggregates counted in AM725 worms, over a 60 h period
upon the onset of young adult stage (set as t = 0). Different aggregation profiles are observed between untreated AM725 worms and the AM725
worms treated on-chip with doxycycline at 15 μg/mL concentration, starting from the L1 stage. Graphs are expressed as mean + SEM (N= 5).
e-f Temporal evolution of worms’ motility over 7 days of adulthood, as observed on NGM plates for (e) doxycycline-treated vs. untreated AM725
worms and (f) mrps-5 RNAi-treated vs untreated AM725 worms
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known to affect the mitochondrial translation in eukaryote
systems [45], we then employ a genetic approach to
impact on the mitochondrial translation machinery. We
silence by RNAi the gene mrps-5 (mitochondrial riboso-
mal protein S5), an important molecular actor for the
mitochondrial translation [42], and we could observe simi-
lar effects on the motility in the ALS model (Fig. 8f). All
together, these results show that doxycycline can prevent
the size expansion of aggregates in a C. elegans model of
ALS, and this improvement correlates with a delay in the
loss of motility.
Conclusions
We introduce a new analytical technique and device for
automated time-resolved studies on C. elegans nema-
todes down to single-worm resolution. Our platform is
based on a multi-functional approach, where several
functionalities are integrated into a single miniaturized
device, to allow fully automated worm analyses. The
device is moreover designed to be compatible with
different microfluidic designs and readily suitable for
different sets of studies.
In our platform, C. elegans nematodes are loaded into
a microfluidic chip, where they are directly distributed
among a set of culture chambers via a “passive valving”
method. Geometrical constraints on the chip allow
retaining only worms of desired size inside the device,
whereas an automated on-chip culture protocol is estab-
lished to ensure their correct feeding and development.
Active control of the chip temperature ensures moreover
running worm cultures at desired temperatures, with
minimal variation throughout long-term analyses. For
screening purposes and high-throughput-like experiments,
our platform can be readily used in imaging experiments
with standard low-magnification microscope objectives.
Moreover, to allow longitudinal high-resolution imaging
of the worms, we optimize an automated procedure for
reversible worm immobilization on-chip. This protocol is
based on the thermoreversible gelation of PF127 poly-
mer inside the device, managed by the closed-loop
temperature control system as well. Any worms’ progeny
is periodically washed out of the chip, with no risk of mix-
ing the identities of the worms under analysis. Therefore,
tests at single-worm resolution can be easily performed
on our platform. Finally, all the microfluidic designs used
in our studies are conceived in a “chamber-matrix”
format, which allows easy automation of the imaging
process as well.
We fully characterize the different functionalities of
our platform, both theoretically and experimentally. We
demonstrate fast and precise temperature management
on the device and provide calibration curves for its use
both in open-loop mode and in closed-loop configur-
ation. We characterize the different integrated worm
handling protocols – i.e. on-chip worm loading, feeding,
immobilization, imaging – and provide details for their
use on the platform. We then employ our device to
tackle the challenging task of analyzing the dynamics of
protein aggregation in ALS worm models over long-
term experiments. Our results show that the device
ensures reliable culture and reproducible growth rate of
the worms over several days. The possibility of isolating
single worms in separated chambers allows collecting
population statistics, while preserving at the same time
all the information related to the single nematodes
under test. For high-resolution imaging experiments, we
employ the on-chip immobilization protocol to tempor-
arily immobilize the worms in a reversible way and
periodically collect data about protein aggregation in
their tissues via high-resolution fluorescent imaging.
Our results show that the amount of SOD1-YFP aggre-
gates in an ALS C. elegans model (AM725 transgenic
worms) linearly increases over the whole analyzed period
(i.e. day 1 to day 4 of adult life). Combined brightfield
and fluorescent imaging at high magnification allows
moreover mapping the geometry of the aggregates,
precisely locate them within the tissues of each worm
and following their progression over consecutive days.
We also demonstrate the suitability of our system for
protein aggregation monitoring in a C. elegans Hunting-
ton disease (HD) model, and demonstrate the systems’s
ability to study long-term doxycycline treatment-linked
modification of protein aggregation profiles in the ALS
model. In fact, the relatively short period needed for the
quantification of a significant increase in SOD1-YFP ag-
gregates opens the possibility for future studies of rapid
identification of ALS modifiers [50]. Because of its good
performance in terms of automation and versatility, we
envision that our system could be employed to address
many other challenging biological questions on C.
elegans, related in particular to the study of neurodegen-
erative diseases – such as Parkinson’s, and Alzheimer’s
disease – which are all modelled in worms [3].
Our platform could moreover be used for studies of C.
elegans movement disorders, for quantifying other
phenotypes such as pharyngeal pumping rates, motility,
etc. or more generally could be used in chemical or
biological laboratories that do in vivo studies and
analyses of multicellular organisms.
Methods
Chemicals and materials
Four-inch 550 μm thick Si and float glass wafers, de-
ionized water (DIW) were obtained from the Center of
Micro- and Nanotechnology of EPFL. GM 1070 SU-8
negative photoresist was purchased from Gersteltec
(Pully, Switzerland). PDMS Sylgard 184 was acquired
from Dow Corning (Wiesbaden, Germany). 1 mL
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borosilicate H-TLL-PE syringes were purchased from In-
novative Laborsysteme GmbH (Stutzerbach, Germany).
Microline ethyl vinyl acetate tube with 0.51 mm inner
and 1.52 mm outer diameters was bought from Fisher
Scientific (Wohlen, Switzerland). Pluronic F-127 was
purchased from Sigma-Aldrich (Buchs, Switzerland). M9
buffer was obtained by adding 3 g KH2PO4, 6 g
Na2HPO4, 5 g NaCl, 1 mL 1 M MgSO4, H2O to 1 l and
sterilization by autoclaving. S-medium buffer was ob-
tained by adding 10 mL 1 M potassium citrate pH 6,
10 mL trace metals solution (1.86 g disodium EDTA,
0.69 g FeSO4 · 7H2O, 0.2 g MnCl2 · 4H2O, 0.29 g ZnSO4 ·
7H2O and 0.025 g CuSO4 · 5H2O, H2O to 1 l) 3 mL 1 M
CaCl2, 3 mL 1 M MgSO4, 1 mL [50 mg/mL] carbenicil-
lin, 0.5 mL tween 20 to 1 l S Basal (5.85 g NaCl, 1 g
K2HPO4, 6 g KH2PO4, 1 mL [5 mg/mL] cholesterol,
H2O to 1 l) and sterilization by autoclaving. Pluronic
F127 solution was prepared by diluting 25 % (weight/vol-
ume) Pluronic F127 in water. Aluminum and polymethyl-
metacrylate (PMMA) assembly parts were fabricated at
the engineering workshop of EPFL. Thermoelectric mod-
ules were bought from TE Technology, Inc. (Traverse
City, MI, USA), heat sinks from Advanced Thermal
Solutions, Inc. (Norwood, MA, USA) and RTD sensors
from Innovative Sensor Technology AG (Ebnat-Kappel,
Switzerland), while a proportional-integral-derivative
(PID) temperature controller was purchased from
BelektroniG GmbH (Freital, Germany).
C. elegans strains and culture
C. elegans strains were cultured at 20 °C on NGM agar
plates seeded with the Escherichia coli strain OP50. Strains
used were wild-type Bristol N2, AM725 (rmIs290[unc-
54p::Hsa-sod-1(127X)::YFP]), AM134 (rmIs126[unc-
54p::Q0::YFP]), AM140 (rmIs132[unc-54p::Q35::YFP]) and
SJ4100 (zcIs13[hsp-6::GFP]) and were provided by the
Caenorhabditis Genetics Center (University of Minne-
sota). Worms were suspended in S-medium solution
prior to each microfluidic experiment. For microflui-
dic experiments, the E. coli strain HT115 was sus-
pended in S-medium at a concentration of 1.4 × 109
cells/mL. Bacterial feeding RNAi experiments were
carried out as described [51]. The clone used was
mrps-5 (E02A10.1). For on-plate motility assays, doxy-
cycline was added at the indicated concentration just
before pouring the plates. Animals were exposed to
compounds from eggs until the day of the
experiment.
Motility assays
C. elegans movement was recorded for 45 s at different
days of adulthood using a Nikon DS-L2/DS-Fi1 camera
and controller setup, attached to both a computer and a
standard brightfield microscope. Five plates of worms,
with 10 worms per plate were measured in each condition.
Using these video recordings, the movement traces of
worms during all recording periods were calculated by
following the organism centroids using a modified version
of the Parallel Worm Tracker for MATLAB [52]. The
average worm speed during the recording periods was
then calculated for each plate and each condition.
Fabrication of the microfluidic chips
Microfluidic devices were prepared by soft lithography
[53] using 2-layer SU-8 molds. Briefly, conventional
photolithography was used to pattern a 14 μm-thick layer
of SU-8 photoresist on 4-in. wafers. A ~110 μm-thick
layer of SU-8 was then patterned on top of the first one.
Layer thicknesses were confirmed by mechanical profil-
ometer measurements. The silicon mold was then diced
in 20 mm× 20 mm microchips, which were inserted at
the bottom of an aluminum/PMMA mold for PDMS
casting (Additional file 1: Supplementary Note 1). 1.5 mm
diameter steel pins were used to define the lateral connec-
tions of the device for the external tubing insertion. A
liquid PDMS mixture (10:1 base:cross-linker weight ratio)
was degassed, injected into the mold and cured at 100 °C
for 1 h. Upon extraction from the mold, each PDMS chip
was bonded by plasma-activation to a 150 μm-thick, 32 ×
24 mm2 glass coverslip. The chip was then connected to
external tubing and enclosed in the device assembly as
reported in Fig. 1a.
Image acquisition and processing
The microfluidic platform was placed within an inverted
microscope (Axio Observer, Zeiss) equipped with two
illumination systems: (i) a precisExcite High-Power LED
illumination system (Visitron, Puchheim, Germany) for
brightfield imaging and (ii) a Lambda DG4 illumination
system (Sutter instruments, Novato, CA, USA) for
fluorescence imaging. The microscope had a motorized
xy-stage and the automated imaging process was
controlled using VisiView Premier Image acquisition
software (Visitron, Puchheim, Germany). Images were
acquired through a Hamamatsu Orca-ER CCD camera
(Hamamatsu, Solothurn, Switzerland). Image processing
was performed with Fiji software (http://imagej.nih.gov/ij;
version 1.47b). In particular, worm areas were measured
by processing time-lapse brightfield pictures as follows.
Each frame was first converted to a binary image by apply-
ing a threshold to the full stack of time-lapse images and
transforming it into a set of binary masks. Each stack of
masks was then analyzed using the “particle analysis” Fiji
plugin, which allows directly extracting area values for
each picture in the stack. The same method was then
applied to the stacks of fluorescence images, in order to
calculate aggregate area values. In this case, we applied a
systematic thresholding algorithm which was based on a
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variational approach, assuring that all aggregates in an
image were effectively counted (i.e. by not setting the
threshold too low), while not resulting in artificial size
reduction of the aggregates (which would be the case by
fixing a too high threshold). The “particle analysis” plugin
allowed measuring the number and the average size of the
aggregates identified in each picture.
Supporting information
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tions; (ii) temperature control system: theoretical consid-
erations; (iii) heat exchange dynamics in the device; (iv)
inflow pre-thermalization study; (v) worm viability and
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